Pharmacokinetics of liver?targeted docetaxel liposomes modified with 6?O?acyl?D?galactose esters in rabbits

Samad A, Sultana Y and Aqil M: Liposomal drug delivery systems: an update review. Curr Drug Deliv. 4:297–305. 2007. View Article : Google Scholar : PubMed/NCBI

Gabizon A, Shmeeda H and Barenholz Y: Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 42:419–436. 2003. View Article : Google Scholar : PubMed/NCBI

Woodle MC and Lasic DD: Sterically stabilized liposomes. Biochim Biophys Acta. 1113:171–199. 1992. View Article : Google Scholar : PubMed/NCBI

Allen TM, Hansen CB and de Menezes DEL: Pharmacokinetics of long-circulating liposomes. Adv Drug Deliv Rev. 16:267–284. 1995. View Article : Google Scholar

Cai L, Wang X, Wang W, et al: Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo. Int J Nanomedicine. 7:4499–4510. 2012.PubMed/NCBI

Mamidyala SK, Dutta S, Chrunyk BA, et al: Glycomimetic ligands for the human asialoglycoprotein receptor. J Am Chem Soc. 134:1978–1981. 2012. View Article : Google Scholar : PubMed/NCBI

Ye Z, Houssein HS and Mahato RI: Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides. 17:349–404. 2007. View Article : Google Scholar : PubMed/NCBI

Li Y, Huang G, Diakur J and Wiebe LI: Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development. Curr Drug Deliv. 5:299–302. 2008. View Article : Google Scholar : PubMed/NCBI

Zhou X, Zhang M, Yung B, Li H, Zhou C, Lee LJ and Lee RJ: Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. Int J Nanomedicine. 7:5465–5474. 2012.PubMed/NCBI

Cheng Y, Wu W, Zhang D and Mai YZ: Enzyme-catalyzed synthesis of ASGPR ligand-targeted modifier in non-aqueous medium. Acta Pharmaceutica Sinica. 45:1134–1138. 2010.(In Chinese).

Guo BH, Cheng Y, Lin LP, Lin DH and Wu W: Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction. J Liposome Res. 21:255–260. 2011. View Article : Google Scholar : PubMed/NCBI

Kuyukina MS, Ivshina IB, Philp JC, Christofi N, Dunbar SA and Ritchkova MI: Recovery of Rhodococcus biosurfactants using methyl tertiary-butyl ether extraction. J Microbiol Methods. 46:149–156. 2001. View Article : Google Scholar : PubMed/NCBI

Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A and Schwudke D: Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 49:1137–1146. 2008. View Article : Google Scholar : PubMed/NCBI

FDA C: Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CV); 2001

Immordino ML, Dosio F and Cattel L: Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 1:297–315. 2006.PubMed/NCBI